![](/img/cover-not-exists.png)
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
Rosell, R., Robinet, G., Szczesna, A., Ramlau, R., Constenla, M., Mennecier, B. C., Pfeifer, W., O'Byrne, K. J., Welte, T., Kolb, R., Pirker, R., Chemaissani, A., Perol, M., Ranson, M. R., Ellis, P. AVolume:
19
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm474
Date:
January, 2008
File:
PDF, 117 KB
english, 2008